ConductScience.org, home

Paper2254635

Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Bénichou C. J Hepatol, 1990. Cited by 908 papers, by iCite.

Cite this record

ConductScience Library. Criteria of drug-induced liver disorders. Report of an international consensus meeting. Papers, record 2254635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2254635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Criteria of drug-induced liver disorders. Report of an international consensus meeting.
PubMed
Journal
J Hepatol
PubMed
Year
1990
PubMed
Publication types
Consensus Statement, Journal Article, Review
PubMed
Citations, by iCite
908
iCite
Relative citation ratio, by iCite
31.9
iCite
Revised in PubMed
2026-01-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bénichou CC

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chemical and Drug Induced Liver InjuryMajor topic
France
Humans
International Cooperation
Pilot Projects

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00828503Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant PatientsBackgroundClinicalTrials.gov
NCT06618573Safety of Administering Isoniazid to SLE Patients to Prevent TBBackgroundClinicalTrials.gov

Download CSV of trials

Cited by332

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 908 citations.

PMIDTitleJournalYearIn PapersSource
42757445Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug-Induced Liver Injury.Liver Int2026https://conductscience.org/library/papers/42757445PubMed
42653701Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653701PubMed
42639177Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI).Front Pharmacol2026https://conductscience.org/library/papers/42639177PubMed
42427211Ceftriaxone-induced liver injury: Incidence, phenotypic characterization and predictive factors.Br J Clin Pharmacol2026https://conductscience.org/library/papers/42427211PubMed
42388594Early Initiation of Adjuvant Nivolumab After Esophagectomy Is Associated With Immune-related Liver Injury.Cancer Diagn Progn2026https://conductscience.org/library/papers/42388594PubMed
42368566Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool.Acta Pharm Sin B2026https://conductscience.org/library/papers/42368566PubMed
42367407Ashwagandha (Withania somnifera)-Associated Liver Injury: A Scoping Review of Clinical Characteristics and Safety Considerations.Cureus2026https://conductscience.org/library/papers/42367407PubMed
42331581Development of phenotype algorithms for the detection of adverse events in electronic health record data: a multicentre study.BMJ Open2026https://conductscience.org/library/papers/42331581PubMed
42003579Fluconazole-induced liver injury in patients with pulmonary cryptococcosis: a comprehensive study integrating clinical cohort analysis, network toxicology, molecular docking, and transcriptomics.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/42003579PubMed
41982764Hepatoprotective Effects of Fused Pyridine Derivatives: Regulation of the TGF-β/Smad, miR-21/Smad7, and PPARγ Pathways in Carbon Tetrachloride-Induced Liver Fibrosis.Drug Des Devel Ther2026https://conductscience.org/library/papers/41982764PubMed
41949784Characteristic histopathology of phenprocoumon-induced liver injury: correlation with clinical presentation and outcome.Virchows Arch2026https://conductscience.org/library/papers/41949784PubMed
41910704A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.Drug Saf2026https://conductscience.org/library/papers/41910704PubMed
41828002Beyond the Pump: The Evolving Molecular Landscape of Intrahepatic Cholestasis.Diagnostics (Basel)2026https://conductscience.org/library/papers/41828002PubMed
41811912Immunophenotypic Stratification of Primary Sjögren's Syndrome Reveals Distinct Lymphocyte Profiles and Clinical Manifestations.J Immunol Res2026https://conductscience.org/library/papers/41811912PubMed
41693786The incidence of chronic drug-induced liver injury: a systematic review and meta-analysis.Front Pharmacol2026https://conductscience.org/library/papers/41693786PubMed
41400033Soft-Drug-Inspired MnSTF Nano-Adjuvant for Safe and Synergistic cGAS-STING Activation in Tumor Immunotherapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41400033PubMed
41399345Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement-Induced Acute Liver Failure Using Whole Exome Sequencing Analysis.Gastro Hep Adv2025https://conductscience.org/library/papers/41399345PubMed
41255460Drug-Induced Liver Injury Associated With Turmeric and Black Pepper Based Dietary Supplements Consumption: A Case Report.Clin Case Rep2025https://conductscience.org/library/papers/41255460PubMed
41158894Probable Cinnamon-Induced Mixed Hepatocellular-Cholestatic Liver Injury in a Young Woman: A Case Report.Cureus2025https://conductscience.org/library/papers/41158894PubMed
41030704The Straw That Broke the Camel's Back: Amoxicillin-Clavulanate Unraveling Autoimmune Hepatitis in a Previously Asymptomatic Female.Cureus2025https://conductscience.org/library/papers/41030704PubMed

See all 332 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2254635

GET https://conductscience.org/api/papers/v1/2254635/cited_by?page=2